Cutting edge: TNF receptor-associated factor 4 restricts IL-17-mediated pathology and signaling processes

Journal of Immunology

Volumn 189, Issue 1, 2012, Pages 33-37

  Zepp, Jarod A ^a,b   Liu, Caini ^a   Qian, Wen ^a   Wu, Ling ^a,b   Gulen, Muhammet F ^a   Kang, Zizhen ^a   Li, Xiaoxia ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; INTERLEUKIN 17; MESSENGER RNA; NUCLEAR FACTOR KAPPA B ACTIVATOR 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 4; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING COMPETITION; BINDING SITE; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; GENE EXPRESSION REGULATION; GENE INDUCTION; LYMPHOCYTE TRANSFER; MOUSE; NONHUMAN; PRIMARY CELL CULTURE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEFICIENCY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TH17 CELL; UPREGULATION; WILD TYPE;

ANIMALS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HEK293 CELLS; HELA CELLS; HUMANS; INTERLEUKIN-17; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RNA, MESSENGER; SIGNAL TRANSDUCTION; TH17 CELLS; TNF RECEPTOR-ASSOCIATED FACTOR 4;

EID: 84862863479     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1200470     Document Type: Article

References (17)

1. Komiyama, Y., S. Nakae, T. Matsuki, A. Nambu, H. Ishigame, S. Kakuta, K. Sudo, and Y. Iwakura. 2006. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 177: 566-573. (Pubitemid 43939170)
2. Nakae, S., A. Nambu, K. Sudo, and Y. Iwakura. 2003. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J. Immunol. 171: 6173-6177. (Pubitemid 37467240)
3. Hu, Y., N. Ota, I. Peng, C. J. Refino, D. M. Danilenko, P. Caplazi, and W. Ouyang. 2010. IL-17RC is required for IL-17A- and IL-17F-dependent signaling and the pathogenesis of experimental autoimmune encephalomyelitis. J. Immunol. 184: 4307-4316.
4. Novatchkova, M., A. Leibbrandt, J. Werzowa, A. Neubüser, and F. Eisenhaber. 2003. The STIR-domain superfamily in signal transduction, development and immunity. Trends Biochem. Sci. 28: 226-229. (Pubitemid 36588662)
5. Chang, S. H., H. Park, and C. Dong. 2006. Act1 adaptor protein is an immediate and essential signaling component of interleukin-17 receptor. J. Biol. Chem. 281: 35603-35607. (Pubitemid 46041290)
6. Qian, Y., C. Liu, J. Hartupee, C. Z. Altuntas, M. F. Gulen, D. Jane-Wit, J. Xiao, Y. Lu, N. Giltiay, J. Liu, et al. 2007. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat. Immunol. 8: 247-256. (Pubitemid 46745374)
7. Liu, C., W. Qian, Y. Qian, N. V. Giltiay, Y. Lu, S. Swaidani, S. Misra, L. Deng, Z. J. Chen, and X. Li. 2009. Act1, a U-box E3 ubiquitin ligase for IL-17 signaling. Sci. Signal. 2: ra63.
8. Hartupee, J., C. Liu, M. Novotny, X. Li, and T. Hamilton. 2007. IL-17 enhances chemokine gene expression through mRNA stabilization. J. Immunol. 179: 4135-4141.
9. Hartupee, J., C. Liu, M. Novotny, D. Sun, X. Li, and T. A. Hamilton. 2009. IL-17 signaling for mRNA stabilization does not require TNF receptor-associated factor 6. J. Immunol. 182: 1660-1666.
10. Bulek, K., C. Liu, S. Swaidani, L. Wang, R. C. Page, M. F. Gulen, T. Herjan, A. Abbadi, W. Qian, D. Sun, et al. 2011. The inducible kinase IKKi is required for IL-17-dependent signaling associated with neutrophilia and pulmonary inflammation. Nat. Immunol. 12: 844-852.
11. Sun, D., M. Novotny, K. Bulek, C. Liu, X. Li, and T. Hamilton. 2011. Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF). Nat. Immunol. 12: 853-860.
12. Zhu, S., W. Pan, P. Shi, H. Gao, F. Zhao, X. Song, Y. Liu, L. Zhao, X. Li, Y. Shi, and Y. Qian. 2010. Modulation of experimental autoimmune encephalomyelitis through TRAF3-mediated suppression of interleukin 17 receptor signaling. J. Exp. Med. 207: 2647-2662.
13. Shiels, H., X. Li, P. T. Schumacker, E. Maltepe, P. A. Padrid, A. Sperling, C. B. Thompson, and T. Lindsten. 2000. TRAF4 deficiency leads to tracheal malformation with resulting alterations in air flow to the lungs. Am. J. Pathol. 157: 679-688. (Pubitemid 30626926)
14. Marinis, J. M., C. R. Homer, C. McDonald, and D. W. Abbott. 2011. A novel motif in the Crohn's disease susceptibility protein, NOD2, allows TRAF4 to downregulate innate immune responses. J. Biol. Chem. 286: 1938-1950.
15. Xiao, H., W. Qian, K. Staschke, Y. Qian, G. Cui, L. Deng, M. Ehsani, X. Wang, Y. W. Qian, Z. J. Chen, et al. 2008. Pellino 3b negatively regulates interleukin-1-induced TAK1-dependent NF kappaB activation. J. Biol. Chem. 283: 14654-14664.
16. Kang, Z., C. Z. Altuntas, M. F. Gulen, C. Liu, N. Giltiay, H. Qin, L. Liu, W. Qian, R. M. Ransohoff, C. Bergmann, et al. 2010. Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis. Immunity 32: 414-425.
17. Zepp, J., L. Wu, and X. Li. 2011. IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease. Trends Immunol. 32: 232-239.